Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. Total Liabilities 2017–2020
Cogent Biosciences, Inc. annual total liabilities history from 2017 to 2020. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cogent Biosciences, Inc. total liabilities as of December 31, 2020: 16.2M, a 8.00% decrease year-over-year.
- Cogent Biosciences, Inc. total liabilities for 2020 were 16.2M, a 8.00% decrease from 2019.
- Cogent Biosciences, Inc. total liabilities for 2019 were 17.7M, a 31.26% decrease from 2018.
- Cogent Biosciences, Inc. total liabilities for 2018 were 25.7M, a 23.46% increase from 2017.
- Cogent Biosciences, Inc. total liabilities for 2017 were 20.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cogent Biosciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2020 | $16 |
| 2019 | $18 |
| 2018 | $26 |
| 2017 | $21 |
Cogent Biosciences, Inc. Total Liabilities — FAQ
Cogent Biosciences, Inc. (COGT) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COGT's total liabilities history?
The chart and table above show Cogent Biosciences, Inc.'s total liabilities by year and by quarter, including the growth rate.